Ashley Prawer
Acute Care · New Hyde Park, NYNPI 1114570215
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 206 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 26 manufacturers, the largest accounting for just 12.5% — the pattern of someone who eats at a lot of different presentations. Among acute care clinicians in NY with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 206 payments — averaging $20.89 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Novartis$539
- Merck$524
- AstraZeneca$510
- E.r. Squibb & Sons, L.L.C.$483
- Pfizer$449
- Edwards Lifesciences$278
- plus $2K from 20 others
What the payments were for
- Food & beverage$4,303100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Novartis | 38 | $539 |
| Merck | 21 | $524 |
| AstraZeneca | 17 | $510 |
| E.r. Squibb & Sons, L.L.C. | 21 | $483 |
| Pfizer | 33 | $449 |
| Edwards Lifesciences | 10 | $278 |
| Medtronic | 7 | $261 |
| Boston Scientific | 9 | $180 |
| Amgen | 9 | $173 |
| Sanofi-aventis U.S. LLC | 5 | $128 |
| Johnson & Johnson | 6 | $109 |
| Novo Nordisk | 5 | $84 |
| Esperion Therapeutics, Inc. | 3 | $74 |
| Abbott | 3 | $69 |
| Lilly USA, LLC | 3 | $64 |
| Regeneron Healthcare Solutions, Inc. | 2 | $63 |
| Alnylam Pharmaceuticals Inc. | 3 | $59 |
| Medicomp Inc | 1 | $54 |
| Azurity Pharmaceuticals, Inc. | 2 | $40 |
| Kiniksa Pharmaceuticals, Ltd. | 2 | $33 |
| Cvrx, Inc. | 1 | $27 |
| Boehringer Ingelheim | 1 | $26 |
| Kiniksa Pharmaceuticals International, PLC | 1 | $23 |
| Heartflow, Inc. | 1 | $20 |
| Scpharmaceuticals Inc. | 1 | $17 |
| Daiichi Sankyo Inc. | 1 | $16 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$4,303 in reported general payments places this provider in the 95th percentile of 980 acute care providers in New York.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| EliquisApixaban | 69 | $82,920 |
| XareltoRivaroxaban | 28 | $27,461 |
| FarxigaDapagliflozin Propanediol | 22 | $23,165 |
| BrilintaTicagrelor | 22 | $18,200 |
| VascepaIcosapent Ethyl | 25 | $15,890 |
| EntrestoSacubitril/Valsartan | 12 | $12,586 |
| MultaqDronedarone Hcl | 15 | $12,574 |
| EdarbiAzilsartan Medoxomil | 17 | $11,437 |
| EdarbyclorAzilsartan Med/Chlorthalidone | 12 | $7,712 |
| Prasugrel Hcl | 23 | $3,573 |
| Metoprolol Succinate | 170 | $2,629 |
| Ranolazine ErRanolazine | 13 | $2,617 |
| Nebivolol Hcl | 22 | $1,684 |
| Atorvastatin Calcium | 162 | $1,681 |
| Diltiazem 24hr Er (Cd)Diltiazem Hcl | 29 | $1,152 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| PfizerEliquis | $449 | $82,92069 claims |
| AstraZenecaFarxiga, Brilinta | $510 | $41,36444 claims |
| Johnson & JohnsonXarelto | $109 | $27,46128 claims |
| NovartisEntresto | $539 | $12,58612 claims |
| Sanofi-aventis U.S. LLCMultaq | $128 | $12,57415 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 980 acute care providers in New York.
Other acute care in New Hyde Park
- Kattalina IsakovNew Hyde Park$8K
- Daniel VerinaNew York$464K
- Michele BiscossiSaratoga Springs$64K
- Heidi YipCanandaigua$29K
- Katie WorthingtonNew York$25K
- Loveth AdenugaNew York$20K
- Katherine DukeNew York$18K
- Ann HarrisBrooklyn$14K
- Marcel RozarioMedina$10K
- Julie Anne RoldanNew York$10K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.